Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

Artificial intelligence (AI) and machine learning have transformed this landscape by enabling complex, predictive alerts ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.

Stavros Papadopoulos, founder and CEO of TileDB, spoke with Pharmaceutical Executive about how modern databases are struggling to handle life sciences data, which in turn limits scientific discovery.

James Foster, CEO and co-founder of Virax Biolabs, discusses how the industry is preparing for potential regulatory changes to vaccine policy.

Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...